fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Mineral oil

All products: general benefit

Fleet Enema Mineral Oil · DIN 00107875 · 100% · Enema

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No interchangeable product listed in the Ontario extract
Fleet Enema Mineral Oil · DIN 00107875 Manufacturer: C.B. Fleet Company Inc.; listing date 1996-10-01 Health Canada: Marketed since 2018-04-02 · brand FLEET ENEMA MINERAL OIL · ATC A06AA01 LIQUID PARAFFIN · form Enema · route Rectal · ingredients MINERAL OIL 100 % · company C b fleet company inc · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

Fleet Enema Mineral Oil: Formulary list price $0.05 per unit (the source does not state the unit; exact figure $0.0474). What the ministry pays, not the patient.

Ministry pays: $0.0474 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00107875)

Source record
DIN 00107875: Fleet Enema Mineral Oil Raw flags: sec3=Y Item: 561200016; group id 653; item number 1635; lccId None; manufacturer id CBF Source form: Enema; strength: 100% Recorded listing: General benefit Source prices (unrounded): $0.0474; ministry $0.0474 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00107875 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=721
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00107875
Shortage record checked October 6, 2026

Other products in the same Health Canada class (A06A, A06AA): coverage varies; not interchangeable

  • Docusate dioctyl sulfosuccinate (Docusate Sodium): general benefit
  • Bisacodyl (Dulcolax): general benefit
  • Citrus fibre + grain (Novo-Fibre): general benefit, not a benefit
  • Lactulose (PMS-Lactulose): general benefit
  • Citric acid + oxide + picosulfate (Pico-Salax): general benefit

Petrolatum/mineral oil

All strengths: Limited Use, Reason for Use code 49 required; same patient cost rules

Shared coverage and patient cost rules
StatusLimited Use, Reason for Use code 49 required
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.

Lacri-Lube · DIN 00210889 · 55% & 42.5% · Oph Oint-3.5g Pk

Limited Use, Reason for Use code 49 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 49 (criteria below)
Ontario Limited Use criteria, code 49
Reason for Use code 49 For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy. Coverage limit: LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Lacri-Lube · DIN 00210889 Manufacturer: Allergan Inc.; listing date 1996-10-01 Health Canada: Marketed since 2024-07-09 · brand REFRESH LACRI-LUBE · ATC S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS. · form Ointment · route Ophthalmic · ingredients MINERAL OIL 42.5 %, WHITE PETROLATUM 57.3 % · company Abbvie corporation · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

Lacri-Lube: Formulary list price $7.90 per unit (the source does not state the unit; exact figure $7.9000). What the ministry pays, not the patient.

Ministry pays: $7.9000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00210889)

Source record
DIN 00210889: Lacri-Lube Raw flags: sec12=Y, sec3=Y Item: 523600070; group id 636; item number 1607; lccId 00091; manufacturer id ALL Source form: Oph Oint-3.5g Pk; strength: 55% & 42.5% Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $7.9000; ministry $7.9000 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00210889 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9820
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00210889
Shortage record checked October 6, 2026

Soothe Night Time · DIN 02125706 · 80%/20% · Oph Oint-3.5g Pk

Limited Use, Reason for Use code 49 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 49 (criteria below)
Ontario Limited Use criteria, code 49
Reason for Use code 49 For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy. Coverage limit: LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Soothe Night Time · DIN 02125706 Manufacturer: Bausch & Lomb Inc.; listing date 1996-10-01 Health Canada: Marketed since 2015-05-29 · brand SOOTHE NIGHT TIME · ATC S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS. · form Ointment · route Ophthalmic · ingredients MINERAL OIL 20 %, PETROLATUM 80 % · company Bausch & lomb inc · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

Soothe Night Time: Formulary list price $5.78 per unit (the source does not state the unit; exact figure $5.7800). What the ministry pays, not the patient.

Ministry pays: $5.7800 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02125706)

Source record
DIN 02125706: Soothe Night Time Raw flags: sec12=Y, sec3=Y Item: 523600076; group id 636; item number 1608; lccId 00091; manufacturer id BLI Source form: Oph Oint-3.5g Pk; strength: 80%/20% Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $5.7800; ministry $5.7800 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02125706 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16777
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02125706
Shortage record checked October 6, 2026

Other products in the same Health Canada class (A06A, A06AA): coverage varies; not interchangeable

  • Docusate dioctyl sulfosuccinate (Docusate Sodium): general benefit
  • Bisacodyl (Dulcolax): general benefit
  • Citrus fibre + grain (Novo-Fibre): general benefit, not a benefit
  • Lactulose (PMS-Lactulose): general benefit
  • Citric acid + oxide + picosulfate (Pico-Salax): general benefit
Other drugs in the same formulary classes and how they are covered

Other drugs in the same formulary class (52:36 Other Eye, Ear, Nose and Throat Agents) and how they are covered

Matched class: 52:36 Other Eye, Ear, Nose and Throat Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: BETAXOLOL HCL, DICLOFENAC SODIUM, LEVOBUNOLOL HCL Some products covered without a code (check the product listing): ACETAZOLAMIDE, METHAZOLAMIDE, SODIUM CROMOGLYCATE, TIMOLOL MALEATE 52:36 Other Eye, Ear, Nose and Throat Agents

ACETAZOLAMIDE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: 250mg · Tab

BETAXOLOL HCL

· 1 products · General benefit · strengths: 0.25% · Oph Susp

DICLOFENAC SODIUM

· 6 products · General benefit · strengths: 0.1% · Oph Sol

LEVOBUNOLOL HCL

· 1 products · General benefit · strengths: 0.5% · Oph Sol

METHAZOLAMIDE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 50mg · Tab

SODIUM CROMOGLYCATE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: 2% · Oph Sol

TIMOLOL MALEATE

· 10 products · Listed, not a benefit (2), General benefit (8) · strengths: 0.25%, 0.5% · Oph Gellan Sol, Oph Sol

AFLIBERCEPT

· 6 products · Limited Use, codes 729, 730, 731 (4), Limited Use, codes 694, 695 (2) · strengths: 2mg/0.05mL, 8mg/0.07mL · Inj Sol-0.05mL Pref Syr (Preservative-Free), Inj Sol-0.07mL Pref Syr, Inj Sol-0.07mL Vial Pk, Sol for Intravitreal Inj-0.05mL Vial Pk

BIMATOPROST

· 8 products · Listed, not a benefit (1), Limited Use, codes 171, 172, 387 (7) · strengths: 0.03%, 0.01% · Oph Sol, Oph Sol-5mL Pk, Oph Sol-7.5mL Pk

BRIMONIDINE

· 7 products · Limited Use, codes 171, 172, 387 · strengths: 0.15%, 0.2% · Oph Sol

BRIMONIDINE TARTRATE & TIMOLOL MALEATE

· 3 products · Limited Use, codes 310, 393 · strengths: 0.2% & 0.5% · Oph Sol-10mL Pk

BRINZOLAMIDE

· 1 products · Limited Use, codes 171, 172, 387 · strengths: 1% · Oph Susp Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 52:36 and 20 more
Full class listing Related classes: 52:04 Anti-Infectives, 52:08 Anti-Inflammatory Agents, 52:16 Local Anesthetics, 52:20 Miotics, 52:24 Mydriatics, 52:32 Vasoconstrictors

Other drugs in the same formulary class (56:12 Cathartics) and how they are covered

Matched class: 56:12 Cathartics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: BISACODYL, DOCUSATE SODIUM (DIOCTYL SODIUM SULFOSUCCINATE), LACTULOSE, MAGNESIUM OXIDE & CITRIC ACID & SODIUM PICOSULFATE, PSYLLIUM MUCILLOID, SENNOSIDES A & B, SODIUM BIPHOSPHATE & SODIUM PHOSPHATE Some products covered without a code (check the product listing): GRAIN & CITRUS FIBRE 56:12 Cathartics

DOCUSATE SODIUM (DIOCTYL SODIUM SULFOSUCCINATE)

· 6 products · General benefit · strengths: 100mg, 4mg/mL, 10mg/mL · Cap, O/L

BISACODYL

· 5 products · General benefit · strengths: 5mg, 10mg · Ent Tab, Sup

GRAIN & CITRUS FIBRE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: · Tab

LACTULOSE

· 1 products · General benefit · strengths: 667mg/mL · O/L

MAGNESIUM OXIDE & CITRIC ACID & SODIUM PICOSULFATE

· 2 products · General benefit · strengths: 3.5g & 12g & 10mg · Pd for Sol-12g Sachet

PSYLLIUM MUCILLOID

· 1 products · General benefit · strengths: · Oral Pd

SENNOSIDES A & B

· 2 products · General benefit · strengths: 8.6mg · Tab

SODIUM BIPHOSPHATE & SODIUM PHOSPHATE

· 2 products · General benefit · strengths: 160mg & 60mg/mL · Ped Rect Sol, Rect Sol (with Preservative) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 56:12
Full class listing Related classes: 56:04 Antacids and Adsorbents, 56:08 Antidiarrhea Agents, 56:16 Digestants, 56:22 Antiemetics and Antinauseants, 56:40 Miscellaneous G.I. Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no link
What the Health Canada label says it is for
Product monograph unavailable: no link